BOVNF OTC
BioInvent International AB (publ)
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -30.0%
5Y: -28.8%
$3.29
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$670M
-32.3% ▼
5Y CAGR: -3.6%
Total Liabilities
$113M
+9.6% ▲
5Y CAGR: +13.9%
Shareholders Equity
$556M
-37.2% ▼
5Y CAGR: -5.6%
Cash & Investments
$591M
-31.8% ▼
5Y CAGR: -4.1%
Total Debt
$10M
-44.5% ▼
5Y CAGR: -3.6%
Net Debt
-$346M
+17.2% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $911M | $515M | $260M | $435M | $355M |
| Short-Term Investments | $172M | $502M | $809M | $432M | $237M |
| Cash & ST Investments | $1.1B | $1.0B | $1.1B | $867M | $591M |
| Net Receivables | $9M | $37M | $12M | $8M | $33M |
| Inventory | $17M | $12M | $12M | $11M | $12M |
| Other Current Assets | $13M | $24M | $28M | $23M | $10 |
| Total Current Assets | $1.1B | $1.1B | $1.1B | $943M | $636M |
| Property, Plant & Equip. | $49M | $52M | $53M | $46M | $33M |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $110M | $74M | -$595M | $0 | $0 |
| Other Non-Current Assets | $172M | $502M | $809M | $0 | $0 |
| Total Non-Current Assets | $331M | $628M | $267M | $46M | $33M |
| Total Assets | $1.4B | $1.7B | $1.4B | $989M | $670M |
| — Liabilities — | |||||
| Accounts Payable | $20M | $41M | $29M | $49M | $105M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Deferred Revenue | $23M | $0 | $0 | $0 | $0 |
| Other Current Liabilities | -$8M | $15M | $13M | $37M | -$18K |
| Total Current Liabilities | $59M | $87M | $76M | $95M | $112M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $1M |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | -$1M |
| Total Non-Current Liabilities | $22M | $19M | $15M | $8M | $1M |
| Total Liabilities | $80M | $106M | $90M | $103M | $113M |
| — Equity — | |||||
| Common Stock | $12M | $13M | $13M | $13M | $0 |
| Retained Earnings | -$2.1B | -$2.1B | -$2.5B | -$2.9B | $0 |
| Accumulated OCI | $1K | $1K | $1K | $1K | $0 |
| Total Stockholders Equity | $1.4B | $1.6B | $1.3B | $886M | $556M |
| Total Liabilities & Equity | $1.4B | $1.7B | $1.4B | $989M | $670M |
| — Key Metrics — | |||||
| Total Debt | $28M | $27M | $23M | $17M | $10M |
| Net Debt | -$882M | -$488M | -$236M | -$417M | -$346M |
| Total Investments | $282M | $576M | $214M | $432M | $237M |